CRVS   $8.27  0.12% Market Open

Corvus Pharmaceuticals Inc
Total Cash 47.25M
totalCashPerShare 0.755
EBITDA -23.27M
Total Debt 700.00K
quickRatio 3.552
currentRatio 3.619
Total Revenue
debtToEquity 1.366
Revenue/Share
ROA -0.23833999
ROE -0.44914
grossProfits
freeCashflow -5.98M
operatingCashflow -21.24M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 530.80M
forwardPE -18.291666
floatShares 38.00M
sharesOutstanding 62.55M
sharesShort 2.44M
sharesShortPriorMonth 1.64M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.44%
Short Ratio help_outline 4.73%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 0.819
Price To Book help_outline 10.72
earningsQuarterlyGrowth
netIncomeToCommon -22.62M
trailingEps -0.43%
forwardEps -0.48%
enterpriseToEbitda -22.81
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.11 3Q 2024
institutionsCount 56
lastUpdated Nov. 7, 2024, 2:26 a.m.